Nimverta Secures Venture Kick Support to Advance Bone Regeneration Therapy
Nimverta, a Zurich-based biotech startup,has secured Venture Kick’s Stage I funding and initial Innosuisse coaching support, marking a new phase in its mission to develop first-in-class peptide therapies for bone regeneration.
Read more